Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonist

Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonist

US Patent 11052065 · Granted Jul 6, 2021

Estimated economic value: $119,175,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Silicone rubber compositions2025
GP130 binding molecules and methods of use2025
Methods, systems, and apparatus to reconfigure a computer2025
IL10RA binding molecules and methods of use2025
IL12 receptor synthetic cytokines and methods of use2025
IL10RB binding molecules and encoding nucleic acids2025
IL2RB binding molecules and methods of use2025
Compositions and methods related to IL27 receptor binding2025
IL27RAlpha binding molecules and methods of use2024
IL10 receptor binding molecules and methods of use2024
Methods and apparatus to facilitate user interaction across multiple computing s2024
IFNGR binding synthetic cytokines and methods of use2024